Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis
- PMID: 19679264
- DOI: 10.1016/j.tcm.2009.05.002
Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis
Abstract
In the recent years, atherogenesis has increasingly been linked to inflammatory processes in the injured vessel wall. Recruitment and arrest of monocytes, T cells, and neutrophils via the concerted actions of multiple chemokines and their chemokine receptors have been the subject of intense research and are being appreciated as key events underlying atherosclerotic lesion formation and progression. The evolutionary conserved cytokine macrophage migration inhibitory factor (MIF) exhibits prominent proinflammatory and proatherogenic functions, and the latest findings on its chemotactic and chemokine-like properties imply MIF as a crucial drug target for the treatment of inflammatory diseases. In this review, the role of MIF in atherosclerosis and injury-induced neointima formation is discussed. We place an emphasis on its proinflammatory and chemokine-like functions in the context of underlying extra- and intracellular signaling mechanisms. These findings clearly distinguish MIF from other cytokines in atherosclerosis and justify the intensive search for inhibitors targeting MIF in the treatment of inflammatory diseases, including advanced atherosclerosis.
Similar articles
-
Macrophage migration inhibitory factor in cardiovascular disease.Circulation. 2008 Mar 25;117(12):1594-602. doi: 10.1161/CIRCULATIONAHA.107.729125. Circulation. 2008. PMID: 18362243 Review.
-
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.Nat Med. 2007 May;13(5):587-96. doi: 10.1038/nm1567. Epub 2007 Apr 15. Nat Med. 2007. PMID: 17435771
-
Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.Circulation. 2004 Jan 27;109(3):380-5. doi: 10.1161/01.CIR.0000109201.72441.09. Epub 2003 Dec 22. Circulation. 2004. PMID: 14691040
-
Chemokines in atherosclerosis: an update.Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1897-908. doi: 10.1161/ATVBAHA.107.161174. Epub 2008 Jun 19. Arterioscler Thromb Vasc Biol. 2008. PMID: 18566299 Review.
-
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.Clin Chim Acta. 2009 Jan;399(1-2):1-7. doi: 10.1016/j.cca.2008.09.014. Epub 2008 Sep 21. Clin Chim Acta. 2009. PMID: 18838066 Review.
Cited by
-
Homocysteine induces inflammatory transcriptional signaling in monocytes.Front Biosci (Landmark Ed). 2013 Jan 1;18(2):685-95. doi: 10.2741/4131. Front Biosci (Landmark Ed). 2013. PMID: 23276953 Free PMC article.
-
Effects of Pulsatility on Arterial Endothelial and Smooth Muscle Cells.Cells Tissues Organs. 2023;212(3):272-284. doi: 10.1159/000524317. Epub 2022 Mar 28. Cells Tissues Organs. 2023. PMID: 35344966 Free PMC article.
-
Atherosclerosis: current pathogenesis and therapeutic options.Nat Med. 2011 Nov 7;17(11):1410-22. doi: 10.1038/nm.2538. Nat Med. 2011. PMID: 22064431 Review.
-
Characterization of molecular determinants of the conformational stability of macrophage migration inhibitory factor: leucine 46 hydrophobic pocket.PLoS One. 2012;7(9):e45024. doi: 10.1371/journal.pone.0045024. Epub 2012 Sep 21. PLoS One. 2012. PMID: 23028743 Free PMC article.
-
Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development.Infect Immun. 2012 Apr;80(4):1399-407. doi: 10.1128/IAI.05861-11. Epub 2012 Jan 17. Infect Immun. 2012. PMID: 22252874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous